Monday 13 October 2025
Home      All news      Contact us      RSS     
scmp - 6 month ago

Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war

Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.


Latest News
Hashtags:   

Hutchmed

 | 

weighs

 | 

cancer

 | 

supply

 | 

chain

 | 

options

 | 

China

 | 

trade

 | 

Sources